Rayno DX and Tools: Hologic (HOLX) added
Hologic (HOLX) Offers Good Long Term Value We will add Hologic Inc. to our Diagnostics and Tools Portfolio. Prior to its acquisition by Hologic we had GenProbe Inc. on our focus list. Hologic (HOLX $21.70), Market Cap of $5.84B, offers good long term value with a Price/Sales of 2.7, book value...
Is There No End to the Biotech Bull Market?
Biotechnology Sector Q2 2013- At All Time Highs The BTK and ETFs such as the IBB and XBI hit all time highs on April 2. Of course the current ramp cannot go on forever because money moves on, speculation ebbs and math intervenes. We have been picking biotech stocks and forecasting this bull...
MO Stock Watch: A Risk Off Day– AMRI, INFI, PCYC etc.-Caution
Pause in Rally as Large Cap Biotechs Are Weak There is significant weakness today in many high fliers that is not apparent in the S&P, NASDAQ and Russell averages. The IBB hit a new high yesterday at the $162 level and is off 1% today. Large Cap leaders YTD are also weak today AMGN, BIIB,...
Biotech Stocks MOve Up Today for Impressive Q1 Performance: BIIB,IBB,GILD,REGN
Rayno Life Science Stocks Having A Nice Q1 Ending Run Well known Large Caps Dominate Rayno focus stocks that are running up 2% + today: AMGN, AMRI, ASTX, BIIB, GILD, QGEN, and REGN. The Biopharma sector is outperforming Tools and Dx for Q1. Tools and DX winners for the week are ALR, ILMN,...
Rayno Life Science Stocks Update and MO Watch: ARRY, INFI, MDVN, PCYC Update 1
Rayno Biopharmaceutical Stocks In a Stealth Rally-Most Core Positions Up No changes have been made in core portfolio positions except as noted below. See update in Seeking Alpha. Action today with strong charts since Feb 26 Sell-Off ALXN ($93) stable and recovering off 1 month lows BIIB ($178)...